title: Dual effects of glucagon and cyclic AMP on DNA synthesis in cultured rat hepatocytes: stimulatory regulation in early G1 and inhibition shortly before the S phase entry.
abstract: Although several lines of evidence implicate cyclic AMP in the humoral control of liver growth, its precise role is still not clear. To explore further the role of cyclic AMP in hepatocyte proliferation, we have examined the effects of glucagon and other cyclic AMP-elevating agents on the DNA synthesis in primary cultures of adult rat hepatocytes, with particular focus on the temporal aspects. The cells were cultured in a serum-free, defined medium and treated with epidermal growth factor (EGF), insulin, and dexamethasone. Exposure of the hepatocytes to low concentrations (10 pM-1 nM) of glucagon in the early stages of culturing (usually within 6 h from plating) enhanced the initial rate of S phase entry without affecting the lag time from the plating to the onset of DNA synthesis, whereas higher concentrations inhibited it. In contrast, glucagon addition at later stages (24-45 h after plating) produced only the inhibition. Thus, if glucagon was added at a time when there was a continuous EGF/insulin-induced recruitment of cells to S phase, the rate of G1-S transition was markedly decreased within 1-3 h. This inhibitory effect occurred at low glucagon concentrations (ID50 less than 1 nM) and was mimicked by cholera toxin, forskolin, isobutyl methylxanthine, and 8-bromo cyclic AMP. The results indicate that cyclic AMP has dual effects on hepatocyte proliferation with a stimulatory modulation early in the prereplicative period (G0 or early G1), and a marked inhibition exerted immediately before the transition from G1 to S phase.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, University of Oslo, Norway.
authors.forename: G H
authors.initials: GH
authors.lastname: Thoresen
authors.forename: T E
authors.initials: TE
authors.lastname: Sand
authors.forename: M
authors.initials: M
authors.lastname: Refsnes
authors.forename: O F
authors.initials: OF
authors.lastname: Dajani
authors.forename: T K
authors.initials: TK
authors.lastname: Guren
authors.forename: I P
authors.initials: IP
authors.lastname: Gladhaug
authors.forename: A
authors.initials: A
authors.lastname: Killi
authors.forename: T
authors.initials: T
authors.lastname: Christoffersen
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology* / Q000502:physiology; D004247:DNA / Q000096:biosynthesis*; D004305:Dose-Response Relationship, Drug; D005934:Glucagon / Q000494:pharmacology* / Q000502:physiology; D007399:Interphase / Q000502:physiology; D008099:Liver / Q000166:cytology* / Q000378:metabolism / Q000502:physiology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
chemical_list: D004247:DNA; D005934:Glucagon; D000242:Cyclic AMP